Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A, Minamino T, Asanuma H, Sanada S, Fujita M, Tsukamoto O, Wakeno M, Myoishi M, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M.
Hirata A, et al. Among authors: minamino t.
Cardiovasc Drugs Ther. 2005 Jan;19(1):33-40. doi: 10.1007/s10557-005-6895-1.
Cardiovasc Drugs Ther. 2005.
PMID: 15883754